Page last updated: 2024-09-03

marimastat and Bone Loss, Osteoclastic

marimastat has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baxter, A; Bird, J; de Groot, H; Deckers, M; Löwik, C; Papapoulos, S; Sijmons, B; van der Pluijm, G; Wills, R	1

Other Studies

1 other study(ies) available for marimastat and Bone Loss, Osteoclastic

Article	Year
In vitro and in vivo endochondral bone formation models allow identification of anti-angiogenic compounds. The American journal of pathology, 2003, Volume: 163, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Bone Development; Bone Resorption; Enzyme Inhibitors; Humans; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Metatarsal Bones; Mice; Models, Biological; Neovascularization, Physiologic; Osteoclasts	2003

Article

Year

In vitro and in vivo endochondral bone formation models allow identification of anti-angiogenic compounds.

The American journal of pathology, 2003, Volume: 163, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Bone Development; Bone Resorption; Enzyme Inhibitors; Humans; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Metatarsal Bones; Mice; Models, Biological; Neovascularization, Physiologic; Osteoclasts

2003